Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sudarshan Chemical Industries Limited (SUDARSCHEM.NS)
Pune, IN
Sudarshan Chemical Industries Limited, along with its affiliated entities, manufactures and distributes a diverse array of organic, inorganic, and effect pigments, in addition to dispersions. The company serves a global market spanning India, the United States, Europe, China, Mexico, Japan, and other international regions. Its operations are structured into two principal divisions: Pigments and an "Others" segment. The extensive range of pigment offerings, sold under renowned brands such as Sudaperm, Sudafast, Sudacolor, Sudadur, Sudafine, Sudajet, Sudasol, Sudatherm, Sudanyl, Sumica, Sumica NXR, Sumicos, and Prestige, are widely utilized in coatings, paints, plastics, inks, cosmetics, and textile applications. Furthermore, Sudarshan Chemical Industries produces industrial equipment, including systems for pollution control, size reduction, pneumatic conveying, and grinding, alongside providing integrated solutions for clean air, material grinding, and conveying needs. Established in 1951, the company's corporate headquarters are situated in Pune, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.91% | +15.56% | +15.36% | +13.17% | -2.94% | +5.85% | -9.21% | +117.06% | +50.24% | +752.66% | +6,818.28% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 1 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+192.5% ★ Q1'26: +106.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-64.4% Q1'26: +1,687.3% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.3% Q1'26: -8.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.9% Q1'26: +8.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.7% ★ Q1'26: +16.5% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+1.4% Q1'26: +21.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.73× ★ Q1'26: 0.91× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2012 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 5 Rev. Ana. 5 EPS Ana. |
Mar 2027 5 Rev. Ana. 5 EPS Ana. |
Mar 2028 5 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.00B
est: 7.40B (+8.1%)
|
12.18B
est: 10.84B (+12.3%)
|
14.09B
est: 11.86B (+18.8%)
|
14.96B
est: 12.85B (+16.4%)
|
14.41B
est: 15.51B (-7.1%)
|
14.57B
est: 15.67B (-7.0%)
|
16.87B
est: 16.41B (+2.8%)
|
18.50B
est: 17.85B (+3.6%)
|
21.91B
est: 22.27B (-1.6%)
|
22.77B
est: 22.44B (+1.4%)
|
25.39B
est: 24.59B (+3.3%)
|
33.46B
est: 27.16B (+23.2%)
|
94.88B
92.76B – 96.70B
+249.3% YoY
|
100.44B
98.26B – 103.45B
+5.9% YoY
|
107.01B
104.48B – 109.77B
+6.5% YoY
|
| EBITDA |
880.13M
est: 1.09B (-19.0%)
|
1.52B
est: 1.59B (-4.3%)
|
1.84B
est: 1.74B (+5.5%)
|
1.87B
est: 1.89B (-1.0%)
|
1.89B
est: 879.72M (+115.2%)
|
2.86B
est: 1.79B (+59.7%)
|
2.67B
est: 2.65B (+0.7%)
|
2.97B
est: 2.49B (+19.2%)
|
2.83B
est: 2.88B (-1.8%)
|
2.14B
est: 3.32B (-35.6%)
|
6.51B
est: 3.78B (+72.1%)
|
3.14B
est: 3.93B (-20.2%)
|
13.92B
13.61B – 14.19B
+254.0% YoY
|
14.74B
14.42B – 15.18B
+5.9% YoY
|
15.70B
15.33B – 16.11B
+6.5% YoY
|
| EBIT |
691.43M
est: 726.45M (-4.8%)
|
1.09B
est: 1.06B (+2.5%)
|
1.31B
est: 1.16B (+12.8%)
|
1.51B
est: 1.26B (+20.0%)
|
1.38B
est: 1.30B (+6.4%)
|
2.17B
est: 1.45B (+49.4%)
|
1.93B
est: 2.22B (-13.1%)
|
2.10B
est: 1.99B (+5.6%)
|
1.94B
est: 2.31B (-16.0%)
|
996.13M
est: 2.66B (-62.5%)
|
5.09B
est: 3.03B (+68.4%)
|
1.47B
est: 2.63B (-43.9%)
|
9.31B
9.10B – 9.49B
+254.0% YoY
|
9.86B
9.64B – 10.15B
+5.9% YoY
|
10.50B
10.25B – 10.77B
+6.5% YoY
|
| Net Income |
335.65M
est: 392.71M (-14.5%)
|
543.79M
est: 542.15M (+0.3%)
|
699.15M
est: 587.73M (+19.0%)
|
1.03B
est: 1.03B (+0.2%)
|
847.25M
est: 660.68M (+28.2%)
|
1.35B
est: 935.05M (+44.5%)
|
1.45B
est: 1.43B (+1.4%)
|
1.41B
est: 1.51B (-6.3%)
|
1.30B
est: 1.74B (-25.4%)
|
447.69M
est: 2.01B (-77.7%)
|
3.57B
est: 2.28B (+56.4%)
|
557.53M
est: 2.20B (-74.6%)
|
248.88M
-156.23M – 538.71M
-88.7% YoY
|
1.32B
823.16M – 1.89B
+432.3% YoY
|
2.79B
1.30B – 4.12B
+110.6% YoY
|
| SGA |
815.08M
est: 706.95M (+15.3%)
|
1.14B
est: 1.04B (+10.4%)
|
687.01M
est: 1.13B (-39.4%)
|
1.04B
est: 1.23B (-15.3%)
|
558.56M
est: 2.97B (-81.2%)
|
556.98M
est: 2.63B (-78.8%)
|
764.72M
est: 1.31B (-41.8%)
|
1.68B
est: 3.55B (-52.7%)
|
1.92B
est: 4.11B (-53.2%)
|
2.01B
est: 4.73B (-57.5%)
|
2.49B
est: 5.39B (-53.8%)
|
3.77B
est: 2.56B (+47.2%)
|
9.06B
8.86B – 9.24B
+254.0% YoY
|
9.59B
9.38B – 9.88B
+5.9% YoY
|
10.22B
9.98B – 10.48B
+6.5% YoY
|
| EPS |
4.85
est: 5.00 (-3.0%)
|
7.86
est: 6.90 (+13.9%)
|
10.10
est: 7.48 (+35.0%)
|
14.64
est: 13.13 (+11.5%)
|
12.24
est: 13.82 (-11.4%)
|
19.52
est: 14.40 (+35.6%)
|
20.88
est: 19.71 (+6.0%)
|
20.38
est: 20.00 (+1.9%)
|
18.77
est: 18.67 (+0.6%)
|
6.47
est: 3.57 (+81.4%)
|
51.60
est: 13.21 (+290.6%)
|
7.90
est: 28.70 (-72.5%)
|
3.13
-1.96 – 6.76
-89.1% YoY
|
16.63
10.34 – 23.72
+432.3% YoY
|
35.03
16.26 – 51.74
+110.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 1.74M | 0.06% |
| 2 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 121.7K | 0.26% |
| 3 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 54.0K | 0.48% |
| 4 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 6.01M | 0.06% |
| 5 | Vanguard ESG International Stock ETF VSGX | 0.00% | 84.9K | 0.10% |
| 6 | Vanguard Total International Stock ETF VXUS | 0.00% | 6.60M | 0.05% |
| 7 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 9.7K | 0.22% |
| 8 | Vanguard Total World Stock ETF VT | 0.00% | 363.2K | 0.06% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 29.1K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 15.6K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Rajesh Balakrishna Rathi | MD & Chairman | 169M | male |
| Ashish V. Vij | Whole Time Director & Vice President of Operations | 24M | male |
| Klaus Baumgart | Chief Technology Officer | — | — |
| Maik Edler | Head of Sales Europe | — | — |
| Mandar Meenanath Velankar | General Counsel, Compliance Officer & Company Secretary | — | male |
| Nilkanth J. Natu | Chief Financial Officer | — | male |
| Sandeep Mhalgi | Chief Information Officer | — | male |
| Aditya Challa | Chief Procurement Officer | — | — |
| Shivalika Raje | Head of People Practices | — | female |
| Geraldo Ventola | Head of Sales South Latam | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SUDARSCHEM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
